Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.

Figure 1: Vaccines licensed so far have all been ... targeted vaccines and updating their formulation every 10 years. Vaccination against meningococcus, a bacterium with five chemically different ...

The trial involved subjects aged 10 to 25 who received the vaccine as ... The company has previously suggested that the 5-in-1 vaccine could eventually become a $1 billion to $2 billion product.

A recent outbreak of measles is prompting questions about the life-threatening disease and how to prevent it. Here's what to ...

The measles outbreak is surging in West Texas, especially in under-vaccinated communities, but it’s not just coverage with ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Health officials say vaccination skepticism is to blame for the states largest Measles outbreak in thirty years, leaving one ...

The standard protective dose is almost 14,000 units, but even 500 units raises antibody levels sufficiently to do the job.

In about 1 in 10,000 who get sick with measles and recover from it, the virus lies dormant in the brain for about a decade.

As first measles death is confirmed in the U.S. since 2015, experts warn the current West Texas outbreak is likely to spread.

Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus, a new Ohio State ...

An unvaccinated school-aged child in Texas has died of measles, the first associated with an outbreak that has infected more ...